Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference

    NEXT STORY
    Guidewires Market to generate revenue of US$2.7 billion by 2025 – TMR
    PREV STORY
    Eyenovia Announces Confirmatory Results from Second MicroStat Phase III Registration Study for Mydriasis
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual Meeting

    BERKELEY, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Tabula Rasa HealthCare’s PACE Division Signs Agreement with CenterLight Healthcare PACE to Manage Medication Risk, Improve Quality and Outcomes

    MOORESTOWN, N.J., Aug. 29, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare Corporation (NASDAQ:TRHC), a ...

    author_avatar
    NASDAQ Market News

    Immunovaccine Announces Year-End 2017 Financial Results

    HALIFAX, Nova Scotia, March 20, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

    author_avatar
    NASDAQ Market News